Please login to the form below
symptoms
This page shows the latest symptoms news and features for those working in and with pharma, biotech and healthcare.
Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
patients. The drug has been shown to cut the recovery time for people hospitalised with severe coronavirus symptoms, although it doesn’t seem to be as effective in those who are
Latest news
-
UK government launches NHS test and trace service
The new NHS test and trace service, which launches today, will test anyone with symptoms of the coronavirus, and will also trace their close contacts. ... Members of their households will still be able to leave the house unless they develop symptoms,
-
New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell
Those with the most severe symptoms who required mechanical ventilation as part of their treatment – who have the highest mortality rate – didn’t appear to benefit from the drug.
-
Gilead, Galapagos dip on mixed ulcerative colitis data
test had a significant impact on symptoms.
-
UK government expands coronavirus testing criteria
The UK government announced this week that every citizen aged five and over with symptoms will now be eligible for a coronavirus test in an effort to determine the spread of ... Prior to this announcement, testing in England and Scotland had been
-
Octapharma cleared to start phase 3 trial of Octagam in COVID-19
The placebo-controlled phase 3 trial will be conducted in seriously-ill COVID-19 patients who are experiencing rapid progression of respiratory symptoms, to see if the drug can stop or
More from news
Approximately 3 fully matching, plus 1,156 partially matching documents found.
Latest Intelligence
-
COVID-19: the race to find a vaccine
to longterm fixes, scouring libraries of existing molecules for ways to kill the virus and manage the symptoms while starting from scratch on products that could deliver the final blow to ... The fact that many people have fairly mild symptoms means
-
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
symptoms including bladder/ bowel dysfunction, high blood pressure and leukaemia, and can reduce life expectancy by up to 15 years.
-
Recruiting for a COVID-19 clinical trial?
Media broadcasts have done a fantastic job of communicating who are at greatest risk of developing severe or deadly symptoms.
-
New truths and realities in these strange times
Many participants in the PoTSLIVE project mentioned increased anxiety, which is a concern as stress can trigger symptom flareups.
-
GSK forges ahead with its dynamic COPD and asthma portfolio
symptom management and reduced mortality.
More from intelligence
Approximately 0 fully matching, plus 117 partially matching documents found.
Latest appointments
-
Srdjan Stankovic joins Acadia Pharmaceuticals
in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.
-
Bayer's Kirstyn Nicholas joins Spirit Healthcare
Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.
-
Ex-Bayer R&D chief joins Gemmus Pharma board
San Francisco-based Gemmus was founded in 2007 and is developing a drug that decreases the severity of flu symptoms by modulating the release of pro-inflammatory cytokines.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Porphyria Awareness Week – Round Up
Symptoms are broad and can vary dramatically in severity, often leaving doctors mystified whilst patients suffer.
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
2) The child may display a variety of different symptoms which do not match one disorder and a clear diagnosis is not reached. ... 3) The child might have an array of symptoms that are in fact an unusual presentation of a known rare condition.
-
Nurses on the frontline – World Health Day 2020
We have both COVID areas and non-COVID areas, so if you are experiencing life-threatening symptoms such as chest pain, please still come to A&E as you would have
-
A Renewed Love of the NHS and National Recovery of the Patient-Doctor Relationship
recognition and management of early and moderate symptoms.
-
Mobile ethnography means no delays to the PoTS LIVE charity project
It is a multisystem disorder that causes a wide range of symptoms which vary on a regular basis and can be triggered by a multitude of factors.
More from PMHub
Approximately 0 fully matching, plus 120 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Regeneron says antibody for COVID-19 could be ready this year
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- Novartis to test canakinumab for COVID-19, as IL-6 trial disappoints
- Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
- AZ secures capacity for one billion coronavirus vaccine doses
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- IFPMA industry association conference: ‘no-one left behind’ on coronavirus vaccine
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- GSK plans to produces one billion doses of vaccine adjuvant for COVID-19
- The big issue
- The field team are off the road! What should they do next?
- INFOGRAPHIC 02: The Importance of clinical study websites
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- The big issue
- Whether you want to lead or follow, you need to understand the elephant in the C-suite...
- INFOGRAPHIC 02: The Importance of clinical study websites
- Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
- Working with, Advocating for, and Empowering Patients
- A holistic view of how to work with patients virtually...
Quick links
Infographics
